These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10893091)

  • 1. Is more NCPAP better?
    Stradling JR; Davies RJ
    Sleep; 2000 Jun; 23 Suppl 4():S150-3. PubMed ID: 10893091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which derivative from overnight oximetry best predicts symptomatic response to nasal continuous positive airway pressure in patients with obstructive sleep apnoea?
    Choi S; Bennett LS; Mullins R; Davies RJ; Stradling JR
    Respir Med; 2000 Sep; 94(9):895-9. PubMed ID: 11001083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response shift in perception of sleepiness in obstructive sleep apnea-hypopnea syndrome before and after treatment with nasal CPAP.
    Chin K; Fukuhara S; Takahashi K; Sumi K; Nakamura T; Matsumoto H; Niimi A; Hattori N; Mishima M; Nakamura T
    Sleep; 2004 May; 27(3):490-3. PubMed ID: 15164904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial.
    Jenkinson C; Davies RJ; Mullins R; Stradling JR
    Lancet; 1999 Jun; 353(9170):2100-5. PubMed ID: 10382693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to nCPAP in patients with coronary disease and sleep apnea without sleepiness.
    Sampol G; Rodés G; Romero O; Jurado MJ; Lloberes P
    Respir Med; 2007 Mar; 101(3):461-6. PubMed ID: 16919928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health status in obstructive sleep apnea: relationship with sleep fragmentation and daytine sleepiness, and effects of continuous positive airway pressure treatment.
    Bennett LS; Barbour C; Langford B; Stradling JR; Davies RJ
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1884-90. PubMed ID: 10351935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment.
    Chin K; Nakamura T; Takahashi K; Sumi K; Matsumoto H; Niimi A; Fukuhara S; Mishima M; Nakamura T
    J Hypertens; 2006 Oct; 24(10):2091-9. PubMed ID: 16957571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spontaneous eye-blink as sleepiness indicator in patients with obstructive sleep apnoea syndrome-a pilot study.
    Caffier PP; Erdmann U; Ullsperger P
    Sleep Med; 2005 Mar; 6(2):155-62. PubMed ID: 15716219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment.
    Gonçalves MA; Guilleminault C; Ramos E; Palha A; Paiva T
    Sleep Med; 2005 Jul; 6(4):333-9. PubMed ID: 15946896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.
    Christou K; Kostikas K; Pastaka C; Tanou K; Antoniadou I; Gourgoulianis KI
    Sleep Med; 2009 Jan; 10(1):87-94. PubMed ID: 18077211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a targeted obstructive sleep apnea consult to improve access and quality at a sleep disorders center.
    Morgenthaler TI; Olson EJ; Gay P; Decker PA; Herold D; Moore W; Silber MH; Krahn L
    J Clin Sleep Med; 2006 Jan; 2(1):49-56. PubMed ID: 17557437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Compliance to treatment recommendations in patients with obstructive sleep apnea at least one year after diagnosis].
    Zgierska A; Pietrzyk A; Pływaczewski R; Zieliński J
    Pneumonol Alergol Pol; 2000; 68(1-2):11-20. PubMed ID: 10967897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of obstructive sleep apnea and daytime sleepiness on work limitation.
    Mulgrew AT; Ryan CF; Fleetham JA; Cheema R; Fox N; Koehoorn M; Fitzgerald JM; Marra C; Ayas NT
    Sleep Med; 2007 Dec; 9(1):42-53. PubMed ID: 17825611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic pressure titration with APAP is as effective as manual titration with CPAP in patients with obstructive sleep apnea.
    Fietze I; Glos M; Moebus I; Witt C; Penzel T; Baumann G
    Respiration; 2007; 74(3):279-86. PubMed ID: 17337881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for lipid peroxidation in obstructive sleep apnea.
    Lavie L; Vishnevsky A; Lavie P
    Sleep; 2004 Feb; 27(1):123-8. PubMed ID: 14998248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual subjective daytime sleepiness under CPAP treatment in initially somnolent apnea patients: a pilot study using data mining methods.
    Nguyên XL; Rakotonanahary D; Chaskalovic J; Philippe C; Hausser-Hauw C; Lebeau B; Fleury B
    Sleep Med; 2008 Jul; 9(5):511-6. PubMed ID: 17921054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of Wakefulness Test, obstructive sleep apnea syndrome, and driving risk.
    Philip P; Sagaspe P; Taillard J; Chaumet G; Bayon V; Coste O; Bioulac B; Guilleminault C
    Ann Neurol; 2008 Oct; 64(4):410-6. PubMed ID: 18688799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.